↓ Skip to main content

Cochrane Database of Systematic Reviews

Snake antivenom for snake venom induced consumption coagulopathy

Overview of attention for article published in Cochrane database of systematic reviews, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
88 Mendeley
Title
Snake antivenom for snake venom induced consumption coagulopathy
Published in
Cochrane database of systematic reviews, June 2015
DOI 10.1002/14651858.cd011428.pub2
Pubmed ID
Authors

Kalana Maduwage, Nick A Buckley, H Janaka de Silva, David G Lalloo, Geoffrey K Isbister

Abstract

Snake venom induced consumption coagulopathy is a major systemic effect of envenoming. Observational studies suggest that antivenom improves outcomes for venom induced consumption coagulopathy in some snakebites and not others. However, the effectiveness of snake antivenom in all cases of venom induced consumption coagulopathy is controversial. To assess the effect of snake antivenom as a treatment for venom induced consumption coagulopathy in people with snake bite. The search was done on 30 January 2015. We searched the Cochrane Injuries Group's Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), Ovid MEDLINE(R), Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid OLDMEDLINE(R), Embase Classic+Embase (OvidSP), three other sources, clinical trials registers, and we also screened reference lists. All completed, published or unpublished, randomised, controlled trials with a placebo or no treatment arm, where snake antivenom was administered for venom induced consumption coagulopathy in humans with snake bites. Two authors reviewed the identified trials and independently applied the selection criteria. No studies met the inclusion criteria for this review. Randomised placebo-controlled trials are required to investigate the effectiveness of snake antivenom for clinically relevant outcomes in patients with venom induced consumption coagulopathy resulting from snake bite. Although ethically difficult, the routine administration of a treatment that has a significant risk of anaphylaxis cannot continue without strong evidence of benefit.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 1%
Unknown 87 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 24%
Student > Bachelor 12 14%
Researcher 9 10%
Student > Doctoral Student 7 8%
Other 5 6%
Other 18 20%
Unknown 16 18%
Readers by discipline Count As %
Medicine and Dentistry 38 43%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Psychology 5 6%
Biochemistry, Genetics and Molecular Biology 4 5%
Other 10 11%
Unknown 20 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2021.
All research outputs
#5,652,156
of 22,817,213 outputs
Outputs from Cochrane database of systematic reviews
#7,509
of 12,317 outputs
Outputs of similar age
#65,911
of 266,368 outputs
Outputs of similar age from Cochrane database of systematic reviews
#176
of 275 outputs
Altmetric has tracked 22,817,213 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,317 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,368 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 275 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.